NEW YORK, Oct. 10 - Agilent Technologies said today it will license proteomics sample preparation technology from Large Scale Biology.
The agreement will allow Agilent to exclusively develop new technologies for the separation of low-abundance proteins from serum samples, said Agilent.
Financial details of the agreement were not disclosed.
In a separate deal, Agilent has licensed the right to exclusively develop and sell software based on Millennium Pharmaceuticals' SpectrumMill mass spectral analysis software. Agilent said the software will help its customers get more information from the company's mass spectrometry-based proteomics products.
The agreement gives Millennium early access to Agilent products and chemistries for proteomics research, according to Agilent.
The companies did not disclose financial details of the agreement.